iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionSevenBridge Financial Group, LLC
Latest Disclosed Ownership1,417 shares
Latest Disclosed Value $ 247,068
SevenBridge Financial Group, LLC reports 10.43% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 23, 2026 - SevenBridge Financial Group, LLC filed a 13F-HR form disclosing ownership of 1,417 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $247,068 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 1,582 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -10.43% during the quarter. The current value of the position is $185,698 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,417 -165 -10.43 247 -11.15 0.0386
2026-02-02 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,582 0 0.00 278 6.92 0.0447
2025-11-13 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,582 0 0.00 261 23.22 0.0430
2025-09-04 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,582 -480 -23.28 212 -15.94 0.0374
2025-05-13 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,062 -672 -24.58 252 -31.61 0.0495
2025-02-12 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,734 -400 -12.76 367 -20.73 0.0694
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,134 -40 -1.26 463 3.81 0.0892
2024-08-09 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,174 -117 -3.56 447 2.06 0.0988
2024-05-10 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,291 -150 -4.36 438 -6.42 0.0991
2024-01-22 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,441 -90 -2.55 468 8.35 0.1104
2023-10-25 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,531 0 0.00 432 -3.79 0.1116
2023-07-26 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,531 -125 -3.42 448 -5.08 0.1158
2023-04-20 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,656 136 3.86 472 2.16 0.1302
2023-01-26 2022-12-31 13F iShares Nasdaq Biotechnology ISHARES BIOTECH 464287556 3,520 648 22.56 462 37.50 0.1351
2022-10-17 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,872 2,872 336 0.1138
2019-10-09 2019-09-30 13F iShares Nasdaq Biotechnology Equities 464287556 0 -312 -100.00 0 -100.00
2019-07-15 2019-06-30 13F iShares Nasdaq Biotechnology Equities 464287556 312 0 0.00 34 -2.86 0.0122
2019-05-14 2019-03-31 13F iShares Nasdaq Biotechnology Equities 464287556 312 7 2.30 35 20.69 0.0131
2019-02-14 2018-12-31 13F iShares Nasdaq Biotechnology Equities 464287556 305 0 0.00 29 -21.62 0.0177
2018-11-14 2018-09-30 13F iShares Nasdaq Biotechnology Equities 464287556 305 0 0.00 37 12.12 0.0197
2018-08-14 2018-06-30 13F iShares Nasdaq Biotechnology Equities 464287556 305 -40 -11.59 33 -10.81 0.0184
2018-05-11 2018-03-31 13F iShares Nasdaq Biotechnology Equities 464287556 345 0 0.00 37 0.00 0.0212
2018-02-16 2017-12-31 13F iShares Nasdaq Biotechnology Equities 464287556 345 230 200.00 37 -2.63 0.0205
2017-11-13 2017-09-30 13F iShares Nasdaq Biotechnology Equities 464287556 115 0 0.00 38 5.56 0.0218
2017-08-14 2017-06-30 13F iShares Nasdaq Biotechnology Exchange Traded Fund 464287556 115 0 0.00 36 9.09 0.0220
2017-05-15 2017-03-31 13F iShares Nasdaq Biotechnology EF 464287556 115 -12 -9.45 33 -2.94 0.0217
2017-02-03 2016-12-31 13F iShares Nasdaq Biotechnology ETF EF 464287556 127 0 0.00 34 0.00 0.0247
2016-12-20 2016-09-30 13F/A-1 iShares Nasdaq Biotechnology ETF EF 464287556 127 0 0.00 34 3.03 0.0248
2016-11-28 2016-09-30 13F iShares Nasdaq Biotechnology ETF EF 464287556 127 34
2016-08-15 2016-06-30 13F iShares Nasdaq Biotechnology ETF EF 464287556 127 127 33 0.0231
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.